Jim Simons’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Jim Simons’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.4K	Buy	+43,002	New	+$196K	﹤0.01%	3141
2025 Q4	–	Sell	-10,830	Closed	-$79.8K	–	3682
2025 Q3	$79.8K	Buy	+10,830	New	+$92K	﹤0.01%	3284
2023 Q3	–	Sell	-1,765	Closed	-$207K	–	4038
2023 Q2	$207K	Buy	1,765 +809	+85%	+$103K	﹤0.01%	3292
2023 Q1	$80K	Sell	956 -59	-6%	-$5.15K	﹤0.01%	3554
2022 Q4	$86K	Buy	+1,015	New	+$77.4K	﹤0.01%	3667
2022 Q3	–	Sell	-910	Closed	-$20K	–	4356
2022 Q2	$20K	Buy	910 +275	+43%	+$9.63K	﹤0.01%	4120
2022 Q1	$31K	Buy	+635	New	+$25.3K	﹤0.01%	3968
2021 Q3	–	Sell	-563	Closed	-$55K	–	3789
2021 Q2	$55K	Buy	+563	New	+$56.7K	﹤0.01%	3387

Other funds holding RVPH

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

WAM

Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jim Simons's RVPH Position: Q1 2026 in Review

Jim Simons opened a new position in REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026: 43,002 shares worth $31.4K. The stake represents ﹤0.01% of the portfolio and ranks #3141 among its holdings. This is a return to the name: Jim Simons previously reported a position in RVPH as recently as Q3 2025.

Jim Simons first reported a position in RVPH in Q2 2021 and has held it in 8 quarters since. The position peaked at $207K in Q2 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

Jim Simons held 43,002 shares of REVIVA PHARMA HLDGS INC worth $31.4K as of Q1 2026.
REVIVA PHARMA HLDGS INC was a new Jim Simons position in Q1 2026.
REVIVA PHARMA HLDGS INC made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3141 holding.
Jim Simons first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and has held it in 8 quarters since.
Jim Simons's REVIVA PHARMA HLDGS INC position peaked at $207K in Q2 2023.
35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.